An extensive screening of GBA1 variants was previously performed by our team (Pachchek et al., 2023) using GBA1-targeted PacBio sequencing in individuals from the Luxembourg Parkinson’s study (660 PD patients, 100 patients with other forms of parkinsonism and 808 controls). Here, GBA1 is linked to Parkinsonism.